New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare blood pressure lowering effect of azilsartan with
that of valsartan in Japanese patients with hypertension who have already taken normal-dose
angiotensin II receptor blockers.
Phase:
Phase 4
Details
Lead Sponsor:
Nara Medical University
Treatments:
Angiotensin II Angiotensin Receptor Antagonists Angiotensinogen Azilsartan medoxomil Valsartan